Trimethobenzamide SUPPOSITORIES (Tigan) will go off the market

Trimethobenzamide SUPPOSITORIES (Tigan) will go off the market...but the oral and injectable forms will stay.

Trimethobenzamide is one of those "unapproved" drugs that came on the market before proof of efficacy was required. Now the FDA is requiring efficacy data...or they'll take these drugs off the market.

There's just not enough evidence the SUPPOSITORIES are effective.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote